These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10954003

  • 1. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.
    Harding P, Carretero OA, Beierwaltes WH.
    J Hypertens; 2000 Aug; 18(8):1107-13. PubMed ID: 10954003
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
    Wang JL, Cheng HF, Harris RC.
    Hypertension; 1999 Jul; 34(1):96-101. PubMed ID: 10406830
    [Abstract] [Full Text] [Related]

  • 3. Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion.
    Castrop H, Schweda F, Schumacher K, Wolf K, Kurtz A.
    J Am Soc Nephrol; 2001 May; 12(5):867-874. PubMed ID: 11316844
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension.
    Okumura T, Hayashi I, Ikezawa T, Yamanaka M, Takata T, Fujita Y, Saigenji K, Yamashina S, Majima M.
    Hypertens Res; 2002 Nov; 25(6):927-38. PubMed ID: 12484518
    [Abstract] [Full Text] [Related]

  • 5. Role of macula densa cyclooxygenase-2 in renovascular hypertension.
    Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, Hilgers KF.
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F498-502. PubMed ID: 12429553
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
    Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L.
    Kidney Blood Press Res; 2004 Mar; 27(4):203-10. PubMed ID: 15273422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs.
    Black SC, Brideau C, Cirino M, Belley M, Bosquet J, Chan CC, Rodger IW.
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):686-94. PubMed ID: 9821840
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2.
    Traynor TR, Smart A, Briggs JP, Schnermann J.
    Am J Physiol; 1999 Nov; 277(5):F706-10. PubMed ID: 10564233
    [Abstract] [Full Text] [Related]

  • 19. Expression and vascular effects of cyclooxygenase-2 in brain.
    Brian JE, Moore SA, Faraci FM.
    Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.